ÂÜÀòÂÒÂ×

Nancy Stratman is a Principal Scientist at Biogen since 2015, specializing in preclinical imaging and pharmacology biomarker discovery and development, focusing on neuroscience target engagement and neuro-imaging tracer development. Prior to Biogen, Nancy Stratman held various roles at Pfizer from 2002 to 2015, including Scientist in the Neuroscience Research Unit where work involved neuropharmacology of psychiatric targets and development of radioligand binding experiments. Earlier, Nancy Stratman worked at Pharmacia from 1998 to 2002 as a Biochemist II, focusing on exploratory investigations for Alzheimer’s disease and anxiety. Nancy Stratman holds a Master of Science and a Bachelor of Science from Western Michigan University, with a major in Biomedical Science and a minor in Chemistry.